Related Experiment Video
Updated: Jul 12, 2026
08:30
A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
Published on: February 14, 2022
Cardiac transplantation: any role left?
Martin Cadeiras1, Manuel Prinz von Bayern, Mario C Deng
1College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
Heart Failure Clinics
|August 29, 2007
Summary
This study evaluates the role of heart transplantation in treating end-stage heart failure amidst advanced medical technologies. It compares transplantation with other therapies like mechanical support and medications to determine its future viability.
Area of Science:
- Cardiology
- Medical Technology
Background:
- End-stage heart failure presents complex treatment challenges.
- Current therapeutic options include pharmacologic management, device therapy, and surgical strategies.
Purpose of the Study:
- To assess the continued relevance of heart transplantation for end-stage heart failure.
- To compare heart transplantation with alternative advanced therapies.
Main Methods:
- Review of existing literature on heart failure treatments.
- Analysis of benefits and drawbacks of various therapeutic modalities.
- Evaluation of technological advancements impacting cardiac care.
Main Results:
- Discussion of pharmacologic, electrophysiologic, and surgical interventions.
- Assessment of mechanical circulatory support devices as alternatives.
- Exploration of heart transplantation's current standing.
Conclusions:
- Heart transplantation remains a critical option for select end-stage heart failure patients.
- Future perspectives suggest a dynamic role for transplantation alongside technological progress.
- Ongoing evaluation is necessary to optimize treatment selection.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...